Author

Yaël P. Mossé

Children's Hospital of PhiladelphiaORCID 0000-0002-3463-0399Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:database / resource· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Alvin FarreliD· 2 shared John M. MarisiD· 2 shared Nathan M. KendserskyiD· 2 shared Adam J. WolpawiD· 1 shared Alaa Narch· 1 shared Anthony C. BryaniD· 1 shared Apexa ModiiD· 1 shared C. Patrick ReynoldsiD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alvin FarrelORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets

Nathan M. Kendsersky, Michal Odrobina, Nathaniel W. Mabe, Alvin Farrel, Liron D. Grossmann, Matthew Tsang, David Groff, Adam J. Wolpaw, Alaa Narch, Francesca Zammarchi, Patrick H. van Berkel, Chi Van Dang, Yaël P. Mossé, Kimberly Stegmaier, John M. Maris

This paper identifies cell state-dependent and -independent immunotherapeutic targets in neuroblastoma by analyzing subtype-specific gene expression and validating targets through experimental methods.

Neuro-Oncology · Jan 17, 2025Peer-reviewedCancer Biology

Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design

Jo Lynne Rokita, Komal S. Rathi, Maria Cardenas, Kristen A. Upton, Joy C. Jayaseelan, Katherine L. Cross, Jacob Pfeil, Laura E. Egolf, Gregory P. Way, Alvin Farrel, Nathan M. Kendsersky, Khushbu Patel, Krutika Satish Gaonkar, Apexa Modi, Esther R. Berko, , John M. Maris

This paper genomically characterizes 261 pediatric cancer patient-derived xenograft models to guide rational clinical trial design and drug development.

Cell Reports · Nov 1, 2019Peer-reviewedGenomics